Literature DB >> 2144522

Induction of GD3 ganglioside by adenovirus E1A gene 13S- and 12S-mRNA products in rat 3Y1 cells.

Y Sanai1, K Oda, Y Nagai.   

Abstract

The effect of the expression of the human adenovirus type 12 E1A gene on ganglioside composition of rat 3Y1 cells was investigated using cell lines established by introduction of recombinant vector DNA containing the E1A 13S- or 12S-mRNA cDNA placed downstream of the hormone-inducible promoter of mouse mammary tumor virus. Ganglioside GD3 was newly detected after switching on of either 13S- or 12S-mRNA cDNA by addition of dexamethasone. A kinetic study indicated that GD3 was expressed 8 h after addition of dexamethasone. Ganglioside GM2 was also accumulated by induction of 13S-mRNA of adenovirus E1A gene. The results indicated that 13S- or 12S-mRNA product alone has the ability to induce GD3 ganglioside in rat 3Y1 cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144522     DOI: 10.1093/oxfordjournals.jbchem.a123118

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

1.  Transformation-associated decrease in cell surface binding of neoglycoenzymes in a temperature-sensitive, virally transformed mouse model.

Authors:  H J Gabius; S Gabius; M Fritsche; G Brandner
Journal:  Naturwissenschaften       Date:  1991-05

2.  Expression cloning of a CMP-NeuAc:NeuAc alpha 2-3Gal beta 1-4Glc beta 1-1'Cer alpha 2,8-sialyltransferase (GD3 synthase) from human melanoma cells.

Authors:  K Nara; Y Watanabe; K Maruyama; K Kasahara; Y Nagai; Y Sanai
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

3.  Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody.

Authors:  M Haraguchi; S Yamashiro; A Yamamoto; K Furukawa; K Takamiya; K O Lloyd; H Shiku; K Furukawa
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.